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Abstract
Purpose Magnetic resonance imaging (MRI) is often used to visualize and diagnose soft tissues. Hearing implant (HI) 
recipients are likely to require at least one MRI scan during their lifetime. However, the MRI scanner can interact with the 
implant magnet, resulting in complications for the HI recipient. This survey, which was conducted in two phases, aimed to 
evaluate the safety and performance of MRI scans for individuals with a HI manufactured by MED-EL (MED-EL GmbH, 
Innsbruck, Austria).
Methods A survey was developed and distributed in two phases to HEARRING clinics to obtain information about the use of 
MRI for recipients of MED-EL devices. Phase 1 focused on how often MRI is used in diagnostic imaging of the head region 
of the cochlear implant (CI) recipients. Phase 2 collected safety information about MRI scans performed on HI recipients.
Results 106 of the 126 MRI scans reported in this survey were performed at a field strength of 1.5 T, on HI recipients who 
wore the SYNCHRONY CI or SYNCHRONY ABI. The head and spine were the most frequently imaged regions. 123 of 
the 126 scans were performed without any complications; two HI recipients experienced discomfort/pain. One recipient 
required reimplantation after an MRI was performed using a scanner that had not been approved for that implant. There was 
only one case that required surgical removal of the implant to reduce the imaging artefact.
Conclusion Individuals with either a SYNCHRONY CI or SYNCHRONY ABI from MED-EL can safely undergo a 1.5 T 
MRI when it is performed according to the manufacturer’s safety policies and procedures.
Keywords Safety · Magnetic resonance imaging · Auditory brainstem implant · Cochlear implant · Bone conduction · 
Middle ear implant
Introduction
Magnetic resonance imaging (MRI) is a commonly used, 
non-invasive imaging modality for diagnostics. Unlike other 
imaging modalities that are typically found in a radiology 
department, such as X-ray or computed tomography (CT), 
MRI scanners do not use ionizing radiation to obtain an 
image. Instead, MRI scanners use strong magnetic fields 
and radio frequency energy [1]. MRI is often the preferred 
imaging modality for the visualization and diagnosis of 
joint injuries that include damage to tendons and ligaments, 
damage to the spinal cord or nerves, intracranial tumors and 
lesions, and neurological diseases.
It was reported that 119 per 1000 people in Germany had 
an MRI scan between 2014 and 2018 [2]. The number of 
MRI scans being performed are continually increasing due 
to technological advancements and expanding indications. 
Unsurprisingly, hearing implant (HI) recipients are likely to 
require at least one MRI scan in their lifetime. Furthermore, 
with people receiving a HI at a younger age and considering 
the possibility of additional health complications that are 
associated with hearing loss, such as diseases of the inner 
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ear, vestibular schwannomas, or neurofibromatosis 2 (NF2), 
the number of MRI scans that are required may be even 
higher [3]. Therefore, it is important to be aware of the safety 
of a HI recipient whilst undergoing an MRI scan.
An MRI scanner has a large magnetic coil that gener-
ates a strong, constant magnetic field. The strength of this 
magnetic field varies from one scanner to another, ranging 
from 0.2 T to 7.0 T or higher. Most radiology departments 
around the world have 1.5 T or 3.0 T MRI scanners, with 
stronger magnets resulting in higher resolution images [1, 
4–7]. Safety is a key concern for HI recipients because a 
strong magnetic field can interact with the internal mag-
net of the HI and result in significant complications for the 
HI recipient [8]. It has been reported in the literature that 
HIs, such as cochlear implants (CIs), auditory brainstem 
implants (ABIs), middle ear implants, or bone conduction 
devices, are associated with unwanted complications during 
an MRI scan. These complications include large artefacts or 
distortions on the MR image, distortion or dislocation of the 
implant magnet, weakening of the implant magnet, demag-
netization, or an increase in temperature in the vicinity of 
the implant [3, 9–17].
Shew et al. evaluated the safety of CI and ABI recipients 
during a 1.5 T MRI, and found that five out of 15 HI recipi-
ents experienced a complication [16]. Many HI recipients 
have also reported pain or discomfort during an MRI scan 
[11, 18]. In 2014, Kim et al. reported that out of 30 scans 
performed on 18 CI recipients, five recipients who wore 
head bandages during their MRI scan were unable to com-
plete their scans due to pain; one recipient required surgical 
reimplantation due to magnet displacement of the implant 
[19]. One solution to this problem is to surgically remove 
the implant magnet before the MRI and surgically replace 
it afterwards. However, two additional operations carry the 
risk of infection, complications from anesthesia, damage to 
the HI, along with the additional costs involved with two 
surgical procedures [20, 21].
MED-EL (MED-EL GmbH, Innsbruck, Austria) have 
developed HIs that are suitable for use within an MRI scan-
ner because removal of the implant magnet is not required. 
MED-EL received a CE mark in 2014 and FDA approval 
in 2015 for the SYNCHRONY to be used in an MRI up to 
3.0 T, with subsequent regulatory approvals in other coun-
tries and regions. The SYNCHRONY has a diametrically 
magnetized and rotatable internal magnet that can turn freely 
and self-align in response to the external magnetic field. A 
diametrically magnetized internal magnet is less likely to 
result in the complications that were previously observed 
with many other HIs that use axially magnetized magnets 
[3, 16].
We distributed surveys in two phases to HEARRING 
clinics and collected data from the clinics on the use of MRI 
for HI recipients. The first phase aimed to evaluate how often 
MRI is used instead of other imaging modalities to image CI 
recipients and what local policies or procedures are in place 
for imaging CI recipients. The second phase aimed to retro-
spectively determine the number of complications reported 
from MED-EL HI recipients following an MRI scan. We 
hypothesize that no complications will be reported when 
MRI scans are performed according to the safety policies 
and procedures outlined by MED-EL [22], but that some 
complications may occur if these policies are not adhered to.
Methods
Phase 1
A survey was developed that consists of five questions about 
the diagnostic imaging modalities used for CI recipients. 
This survey was distributed to HEARRING clinics (see 
Appendix A) and each clinic was given two weeks to com-
plete the survey. This survey was used to obtain information 
about the imaging modality that is most often used to image 
the head region of a CI recipient, how often radiologists 
refused to perform an MRI on a CI recipient, and if there 
were any local policies in place for imaging CI recipients.
Phase 2
Following analysis of the results from the first survey, a sec-
ond survey was distributed to the same HEARRING clinics 
to retrospectively collect information relating to MRI scans 
that were performed on recipients of MED-EL HIs (this 
included CI, ABI, middle ear implants, and bone conduction 
devices). The survey asked questions relating to the age of 
the HI recipient at the time of the MRI scan, the body region 
scanned, and the reason for the MRI. Information was also 
requested about the implant model, date of implantation, 
field strength of the MRI scanner, if a protective head band-
age was used, and whether there were any complications 
during the MRI scanning procedure. The survey also asked 
if the imaging artefact affected the ability to diagnose the 
HI recipient and if users with a SYNCHRONY HI had the 
magnet removed prior to scanning.
Clinics were asked to complete the survey for every HI 
recipient that received an MRI scan between December 2013 
and April 2018. This survey only collected anonymized data 
and information from health records available at each clinic. 
The survey could be completed online or completed offline 
and returned via email.




Results from the first phase of the survey were collected 
from 26 HEARRING clinics, as shown in Table 1. The 
survey respondents at each participating clinic were CI 
surgeons currently active at the clinics and who reported 
on their experiences. The results showed that CT and MRI 
were both used to image the head region of CI recipients. 
Ten clinics stated that their decision to either use CT or 
MRI depended on the pathological investigation. Twelve 
clinics were aware of radiologists who refused to perform 
an MRI of the head region on a CI recipient and 12 clinics 
were unaware of such cases occurring. Of those clinics 
who were aware of radiologists who refused to perform 
MRIs on CI recipients, only three reported that radiolo-
gists were concerned about performing MRI scans on per-
sons who were implanted with hearing devices. Nineteen 
clinics did not have a general policy for the removal of 
the CI’s internal magnet prior to imaging. Four clinics 
noted that their radiology department had the policy that 
CI recipients should typically be imaged using CT instead 
of MRI, whereas 19 clinics noted that this was not a policy 
in their radiology department.
Phase 2
The second phase was completed by 17 of the 26 HEAR-
RING clinics that received the survey. The results from 
this phase reported on the number of MRI scans that were 
performed on 88 recipients of MED-EL HIs between 
December 2013 and April 2018. This group of HI recipi-
ents consisted of 46 females and 41 males (one recipient’s 
gender was not reported). Seventy-eight recipients were 
unilaterally implanted and 10 were bilaterally implanted. 
Seventy-five recipients were adults (mean age at the time 
of MRI 55.6 years; standard deviation ± 18.0 years; range 
18–83 years) and 10 were children (mean age at the time 
of MRI 5.4 years; standard deviation ± 5.8 years; range 
1–17 years); the age of 3 recipients were not reported. The 
mean time period between implantation and receiving an 
Table 1  Results from Phase 
1 of the survey. Twenty-six 
HEARRING clinics were asked 
how often MRI was used for 
cochlear implant (CI) recipients 
and whether local policies 
are in place at each clinic for 
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MRI was 2.4 years (standard deviation ± 2.1 years; range 
0.2–10 years).
Between December 2013 and April 2018, a total of 126 
scans were performed at different field strengths on this 
group of 88 HI recipients. It should be noted that irrespec-
tive of whether recipients were uni- or bilaterally implanted, 
some recipients may have had more than one scan on their 
device(s): 73 HI recipients had one MRI scan (73 scans); 
eight had two scans (16 scans); four had three scans (12 
scans); two had four scans (8 scans); and one HI recipient 
had five scans (5 scans). This accounts for 114 of the 126 
reported scans. In terms of the scans performed on bilater-
ally implanted recipients, 8 recipients had only one scan (8 
scans) and two recipients had two scans (4 scans), which 
accounts for the remaining 12 scans reported in the survey.
Table 2 provides a list of the type and model of HIs that 
the 88 recipients wore that resulted in the 126 scans reported 
in the survey. Table 2 also shows the number of times a 
type and model of the device was scanned at a particular 
magnetic field strength. The majority of HI recipients that 
underwent an MRI scan had a CI in one of the five models 
listed in the table; other HIs included the BONEBRIDGE 
BCI 601 bone conduction device, SOUNDBRIDGE VORP 
503 middle ear implant, SYNCHRONY ABI, or other non-
MED-EL implants (implanted on the contralateral side of 
bilateral HI recipients). A protective head bandage was used 
for 72 scans (i.e., 28 SYNCHRONY; 15 SYNCHRONY 
ABI; 20 CONCERTO; 9 SONATA; 4 BONEBRIDGE BCI 
601; 3 PULSAR; 2 COMBI40 + ; 0 VORP 503; 2 other), not 
used for 23 scans, and it was not specified if a head bandage 
was used for 19 scans.
Most of the MRI scanners reported in this survey had a 
1.5 T coil (106 scans), 11 scanners had a 3.0 T coil, one had 
a 0.2 T coil, and eight were unknown or unspecified. This 
accounts for the 126 scans reported by survey respondents. 
Table 3 shows the regions that were imaged during each 
Table 2  Type and model of MED-EL hearing devices (MED-EL GmbH, Innsbruck, Austria) worn by the 88 HI recipients that were reported in 
Phase 2 of the survey
Ndevice denotes the number of MRI scans that were performed on each model of the types of hearing devices reported in the survey. NT denotes 
the number of MRI scans that were performed on each model of the types of hearing devices. Answer options consisted of magnetic field 
strengths 0.2, 1.5, and 3.0 T, and “other” and “unknown”; “other” was an answer option for cases where the field strengths were known to survey 
respondents but were not one of the numerical field strength options; “unknown” denotes field strengths that were not known to survey respond-
ents
*Hearing implant from another company
Type Model Ndevice
(number of MRI scans 
per model of device)
NT
(number of MRI scans at different field 
strengths for each model of device)
0.2 T 1.5 T 3.0 T Other Unknown
Cochlear implant COMBI40/COMBI40 + 4 0 3 1 0 0
PULSAR 4 0 3 1 0 0
SONATA 11 0 9 0 0 2
CONCERTO 24 0 24 0 0 0
SYNCHRONY 48 0 35 9 1 3
Bone conduction device BONEBRIDGE BCI 601 6 0 4 0 2 0
Middle ear implant SOUNDBRIDGE VORP 503 2 1 1 0 0 0
Auditory brainstem implant (ABI) SYNCHRONY 24 0 24 0 0 0
Other implant* 3 0 3 0 0 0
Table 3  The region of the body that was imaged during each MRI 
scan and the reasons for performing the MRI scan
N














 Pre-implantation of the second ear 6
 Other 17
 Unknown 15
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MRI scan and the reasons for performing the scan. The 
head and spine were the bodily regions that were scanned 
most frequently in HI recipients, with 77 scans of the head 
and 24 scans of the spine reported in the survey. The main 
reasons for performing the MRI scans were for monitoring 
NF2, neurological diseases, and for musculoskeletal/injury 
investigations.
For MRI scans of the head region, the artefact produced 
by the HI still allowed for diagnosis in 12 scans and limited 
diagnosis in 23 scans. Diagnosis was not possible for 13 
scans and it was unknown if the artefact affected the diagno-
sis in 29 scans. For cases where the diagnosis was not pos-
sible, either a CT scan was performed, or an MRI scan was 
performed using a 1.5 T scanner instead of a 3.0 T scanner. 
The use of a scanner with a weaker magnetic field strength, 
i.e., 1.5 T instead of 3.0 T, reduced the artifact from the HI. 
Limited diagnosis was caused by distortion and susceptibil-
ity artefacts from the HI.
For users of the SYNCHRONY CI device, the internal 
magnet was only removed from one recipient prior to the 
MRI. In this case, the MED-EL magnet removal toolkit 
and non-magnetic spacer were not used. It was not reported 
whether the magnet was removed prior to the MRI for the 
other SYNCHRONY recipients.
In terms of other implants that this group of HI recipients 
had, it was reported that four scans were performed on three 
people that had another non-hearing implant. One had a hip 
implant (and underwent two MRI scans); one had titanium 
dental implants (one MRI scan); and one had an unknown 
additional implant (one MRI scan).
Adverse events
During two different MRI scanning events, HI recipients 
reported discomfort and unexpected sensations. Both users 
were bilaterally implanted. Recipient #1 wore a SONATA 
on the right side and a non-MED-EL implant on the 
left. Recipient #2 wore a PULSAR on the right side and 
a COMBI40 + on the left. It was noted that the pain was 
related to the non-MED-EL side (left side) for Recipient 
#1, but it was not specified if the sensations were restricted 
to one side or on both sides for Recipient #2. One of the 
scans was aborted after the discomfort was reported. All 
devices worked properly afterwards without any further 
complications.
During a 0.2 T MRI scanning event, dislocation of the 
floating mass transducer (FMT) was observed for one 
SOUNDBRIDGE VORP 503 middle ear implant recipient 
after the MRI was performed outside of the recommended 
safety policies and procedures; this implant has not been 
approved for a 0.2 T MRI. The user was a unilaterally 
implanted male adult undergoing an MRI of the head region. 
A head bandage was not used during the scan. The recipient 
also reported a lack of auditory sensations after the MRI. 
The recipient was later reimplanted and the implant was 
returned to the manufacturer for further evaluation, where 
it was found that there was no damage to or weakening of 
the FMT magnet.
No adverse events were reported during the other 123 
MRI scans reported during this investigation.
Discussion
The results of Phase 1 of the survey were obtained from 
26 HEARRING clinics and showed that CT and MRI were 
both used to image the head region of CI recipients. Twelve 
clinics reported that they were aware of radiologists who 
refused to perform an MRI on a CI recipient; however, only 
three clinics had a negative experience while performing 
an MRI on a CI recipient. It is thought that many radiology 
departments are unfamiliar with the differences between 
the various types of HI devices and are not aware of which 
implants are compatible with MRI. Therefore, further infor-
mation should be distributed to radiologists regarding the 
MRI safety and compatibility of implants from different 
manufacturers. In 19 of the 26 clinics that participated in 
this survey, there were no policies in place regarding the 
removal of the CI’s internal magnet prior to MRI scanning 
or that CI recipients should receive a CT scan instead of an 
MRI scan. The results of this survey led to the development 
of a second survey that aimed to collect further information 
relating to all MED-EL HIs and to evaluate their safety and 
performance during an MRI scan.
Phase 2 of the survey showed that 126 MRI scans were 
performed on 88 HI recipients in 17 HEARRING clinics 
between December 2013 and April 2018. The majority of 
the HI recipients (73 out of 88) required only one MRI over 
this timeframe, however, there were some HI recipients who 
required up to five scans. It is interesting to note the distri-
bution of HI devices in terms of the number of MRI scans 
that were performed. Out of 123 scans that were performed 
on different types and models of MED-EL HIs, 48 scans 
were performed on the SYNCHRONY CI and 24 scans 
were performed on the SYNCHRONY ABI. The remaining 
3 scans were performed on HIs from other manufacturers. 
The majority of scans (106 out of 126) were performed at 
1.5 T. Eleven scans were performed at 3.0 T, of which 9 
out of the 11 scans were performed on SYNCHRONY CI 
recipients. The results of our two-phase survey are thus most 
indicative of the frequency of use and safety of MRI scans at 
a field strength of 1.5 T when the HI recipient wears either 
the SYNCHRONY CI or the SYNCHRONY ABI. Only one 
scan performed at a field strength of 0.2 T was reported. This 
seems to indicate that 0.2 T MR imaging of HI recipients is 
no longer routinely performed.
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A cadaveric study previously demonstrated that 25% of 
implants (4 out of 16) moved during a 1.5 T MRI when 
performed without a compressive head wrap, compared to 
0 of 16 when a compressive head wrap was used [23]. In 
our survey, most of the clinics reported that they used a 
protective head bandage during MRI scans, even though it 
was not a safety requirement. Assuming that the MRI is per-
formed according to the manufacturers’ safety policies and 
procedures, the use of a head bandage is optional for the fol-
lowing MED-EL implants: SYNCHRONY, SYNCHRONY 
2 (including PIN and ABI variants), SYNCHRONY ST, 
BONEBRIDGE BCI 601, BONEBRIDGE BCI 602, and 
SOUNDBRIDGE VORP 503. All other models from 
MED-EL require a simple elastic head bandage that should 
be wrapped around the head at least 3 times. The bandage 
should sit firmly on the head but should not cause any pain 
to the HI recipient.
Sixty percent of MRI scans reported in our survey were 
performed to image the head region, with the spine being the 
second most common region scanned. The distribution of 
MRI scans taken over various regions of the body are simi-
lar to those published by Grupe et al. [8] and Walker et al. 
[15]. The most common reasons to perform an MRI on a HI 
recipient were for monitoring NF2, neurological diseases, 
and for muscloskeletal/injury investigation. It is important 
to note that this survey only pertained to the health records 
of HI recipients that were available at each clinic. There may 
have been additional MRI scans of other body regions, such 
as the knee, or for unrelated conditions that were performed 
in outpatient centers that were not included here.
For MRI scans of the head region, the imaging artefact 
still allowed for a full diagnosis, or for a limited diagnosis in 
the majority of cases. When the diagnosis was not possible, 
CT imaging or MRI using a lower field strength (i.e., 1.5 T 
instead of 3.0 T) were performed. Similar results have been 
published in other studies, including studies with HIs from 
other manufacturers [12, 15, 16]. The mean artefact size 
was previously reported as 7.43 cm along the long axis and 
4.16 cm along the short axis [19], with more pronounced 
artefacts observed with a 3.0 T MRI scanner in comparison 
to a 1.5 T MRI [24]. For cases where MRI is required to 
evaluate brain pathologies on the implanted side of a HI 
user, it may be possible to reduce the artefact by selecting a 
suitable MRI sequence with an optimized set of parameters 
and artefact reduction sequences. If this is not sufficient and 
the imaging artefact still affects the diagnosis, then it is pos-
sible to surgically remove the implant magnet [24, 25].
The SYNCHRONY HI received a CE mark (in 2014) 
and FDA approval (in 2015) for use in an MRI scanner 
with field strengths up to 3.0 T. There have only been a few 
reported cases where the removal of the internal magnet 
was necessary to reduce the imaging artefact [26, 27]. To 
the best of our knowledge, no complications following the 
removal of the SYNCHRONY magnet have been reported. 
According to our survey respondents, the magnet was only 
removed from one SYNCHRONY HI recipient prior to an 
MRI and no adverse events were reported. This is in agree-
ment with published reports that the freely rotating mag-
net in the SYNCHRONY allowed recipients to undergo an 
MRI without experiencing pain or discomfort, and without 
magnet dislocation or demagnetization, even at 3.0 T [10, 
16, 28]. Nonetheless, if it is required to remove the magnet 
from a SYNCHRONY implant prior to an MRI (e.g., due to 
the presence of an imaging artefact in the region of interest), 
then it should be possible to do so safely [26, 27].
Individuals who require regular MRI surveillance of par-
ticular regions of the head should be carefully counselled 
prior to receiving a HI. It is recommended that individu-
als who require regular MRI surveillance of regions of the 
head should receive a HI with a removable magnet, such as 
the SYNCHRONY, which allows for the easier removal and 
reinsertion of the implant magnet. Helbig et al. [27] reported 
a study involving a young child with bilateral SYNCHRONY 
implants. The child required magnet removal prior to an 
MRI so that a case of hydrocephalus could be investigated. 
The total time required for two surgical procedures was 1 h 
45 mins or 3 h 15mins including the MRI scan; there were 
no complications reported during the entire procedure.
Our survey found that a large majority of MRI scans were 
performed on MED-EL HI recipients without any compli-
cations. There were no dislocations or weakening of the 
implant magnet when the MRI was performed while fol-
lowing MED-EL’s safety policies and procedures [22]. Only 
one case was reported in our survey where a surgical proce-
dure was required for reimplantation of a device: a recipient 
of the SOUNDBRIDGE VORP 503 implant was scanned 
with a 0.2 T MRI even though this middle ear implant has 
only been approved for use at 1.5 T and not at 0.2 T. Todt 
et al. reported that a 1.5 T MRI was performed on SOUND-
BRIDGE VORP 503 users. All scans were performed 
without any degree of pain, change in pure tone audiom-
etry results, or audio processor fittings [34]. Several studies 
have documented cases in which recipients of the SOUND-
BRIDGE had an MRI at a magnetic field strength for which 
the SOUNDBRIDGE is not approved, yet no adverse events 
or complications were reported [16, 29–31]. Nonetheless, 
there have been many reports of adverse events, where HI 
recipients of devices by other manufacturers experienced 
pain, magnet dislocations, heating of the implant, induction 
of electrical current that damaged or resulted in malfunction-
ing of the implant, or demagnetization of the internal HI 
magnet [3, 12, 15–17, 19, 32, 33]. Having said that, there 
were no reports of damage to hearing nerves, loss in the 
ability to hear with the HI after the MRI, or long-term pain 
or uncomfortable sensations from any MED-EL HI recipi-
ents after the MRI in any of the clinics who completed our 
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survey. Previous studies reported pain as the most common 
complication during an MRI for HI users [3, 8], with clini-
cians often having to stop the MRI scan due to the level of 
pain experienced [19]. There were only two cases reported 
in our survey where the HI recipients experienced discom-
fort or unexpected sensations during the MRI; there were 
no further complications after the MRI for either of these 
individuals.
Many studies have been published about the outcomes of 
MRI in individuals with a CI from Cochlear Ltd. (Sydney, 
Australia), however, outcomes with CIs from other manu-
facturers and other HIs such as ABIs, middle ear implants, 
or bone conduction devices are not often reported. In our 
survey, we found no reports of complications with ABI 
devices. Only one complication was observed with a mid-
dle ear implant whereby the MRI scan was performed with a 
field strength of 0.2 T, for which the implant has not received 
approval. Therefore, it is important for clinics and radiol-
ogy departments to perform MRIs in accordance with the 
safety policies and procedures that have been released by 
each manufacturer to avoid unnecessary adverse events or 
additional surgical procedures for the HI recipient.
Limitations and future studies
As previously discussed, this investigation involved the dis-
tribution of surveys and the retrospective collection of data 
from the health records of HI recipients that were available 
within each HEARRING clinic, and as such, there may have 
been additional MRI scans performed in outpatient centers 
that were not included here. Furthermore, due to the nature 
of an investigation that relies on survey responses that are 
based on health records, it is possible for some inaccura-
cies to have been reported. The responses to our survey are 
indicative of the frequency of use and safety considerations 
pertaining to 1.5 T MRI scans that are routinely performed 
on recipients of SYNCHRONY CIs and SYNCHRONY 
ABIs. Only a small number of responses pertained to field 
strengths other than 1.5 T (in particular, 0.2 T and 3.0 T), 
other MED-EL devices, and devices from other manufactur-
ers. Thus, we cannot draw any reliable conclusions on those 
scenarios based on the survey responses that were collected. 
Nonetheless, the data obtained is still valuable and useful 
for developing strategies to create greater awareness of the 
safety issues relating to MRI scanning of HI recipients: the 
data is indicative of where radiology departments might lack 
the knowledge and experience in performing MRIs at dif-
ferent field strengths on different types of HIs from differ-
ent manufacturers. Three survey responses selected the field 
strength option “Other”, which indicated that it was known 
to the survey respondent that the field strength used was 
other than the answer options 0.2, 1.5, and 3.0 T. It would 
have been of interest to know what those field strengths were 
and what the radiologists’ reasons were for scanning at those 
field strengths. This raises the question of the routine use 
of other field strengths, particularly those between 1.5 and 
3.0 T (e.g., 2.5 T), and radiologists’ knowledge, experience, 
and confidence in MR imaging of HI recipients at those field 
strengths. Survey design should therefore provide respond-
ents with the possibility to elaborate on their answers as 
much as possible.
Future studies might consider investigating the ability to 
visualize the internal acoustic canal, cerebellopontine angle, 
or other features of the inner ear from an MRI scan of a HI 
recipient—this would be particularly interesting when fol-
lowing individuals with vestibular schwannomas or NF2. 
Small studies have been performed on this topic [35], but 
a large-scale study covering a wide range of HIs would be 
invaluable.
Conclusion
The safety of the HI recipient during an MRI scan is a prior-
ity for clinics across the world. Results of this survey, which 
was conducted in two phases, found that individuals with 
either the SYNCHRONY CI or SYNCHRONY ABI, both 
devices manufactured by MED-EL, can safely undergo an 
MRI at a field strength of 1.5 T provided that the scan is 
performed according to the manufacturer’s safety policies 
and procedures. Therefore, radiology departments should 
become familiar with these and be willing to perform an 
MRI on a SYNCHRONY CI or ABI recipient when required.
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tary material available at https:// doi. org/ 10. 1007/ s00405- 020- 06525-3.
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